Lifeward

Lifeward FCF Growth

The Year-over-Year Free Cash Flow Growth of Lifeward (LFWD) as of Nov 22, 2026 is 22.45 %. In the previous year, Year-over-Year Free Cash Flow Growth was -4.68 % — a change of -580.23% (higher).

FCF Growth

22.45 %

YoY

-580.23%

Last updated:

Year-over-Year Free Cash Flow Growth of Lifeward is 2025 22.45 % . Year-over-Year Free Cash Flow Growth of Lifeward was 2024 -4.68 % . It decreases by -580.23% higher compared to the previous year.

The Lifeward FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2018
34.34 USD
Jan 1, 2019
-0.34 USD
Jan 1, 2020
14.66 USD
Jan 1, 2021
9.05 USD
Jan 1, 2022
-55.57 USD
Jan 1, 2023
-15.81 USD
Jan 1, 2024
-4.68 USD
Jan 1, 2025
22.45 USD
The Lifeward FCF Growth history
YEARFCF GrowthYoY
22.45 %-580.23%
-4.68 %-70.42%
-15.81 %-71.56%
-55.57 %-714.04%
9.05 %-38.26%
14.66 %-4,435.34%
-0.34 %-100.98%
34.34 %+75.69%
19.54 %-326.30%
-8.64 %-86.98%
-66.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

Year-over-Year Free Cash Flow Growth of Lifeward is 22.45 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Lifeward since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Lifeward historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Lifeward

All Key Metrics — Lifeward